Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1978 1
1979 1
1980 2
1981 2
1982 2
1983 3
1984 3
1985 1
1986 4
1987 6
1988 3
1989 4
1990 5
1991 6
1992 8
1993 7
1994 1
1995 7
1996 5
1997 3
1998 9
1999 6
2000 5
2001 6
2002 6
2003 12
2004 9
2005 12
2006 9
2007 9
2008 8
2009 5
2010 7
2011 11
2012 17
2013 15
2014 10
2015 13
2016 9
2017 7
2018 13
2019 13
2020 13
2021 18
2022 20
2023 11
2024 13
2025 24
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

364 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean trentin wilson disease (1 results)?
Trientine dihydrochloride for Wilson's disease.
[No authors listed] [No authors listed] Aust Prescr. 2021 Jun;44(3):111. doi: 10.18773/austprescr.2021.022. Epub 2021 Apr 29. Aust Prescr. 2021. PMID: 34211251 Free PMC article. Review. No abstract available.
Wilson's disease: overview.
Lucena-Valera A, Ruz-Zafra P, Ampuero J. Lucena-Valera A, et al. Med Clin (Barc). 2023 Mar 24;160(6):261-267. doi: 10.1016/j.medcli.2022.12.016. Epub 2023 Jan 23. Med Clin (Barc). 2023. PMID: 36697289 Review. English, Spanish.
Wilson's disease (WD) is an uncommon hereditary disorder caused by a deficiency in the ATP7B transporter. ...The treatment must be maintained lifelong and includes some drugs such as chelating agents (penicillamine and trientine) and inhibitors of the copper …
Wilson's disease (WD) is an uncommon hereditary disorder caused by a deficiency in the ATP7B transporter. ...The treatment mus …
Wilson Disease: Diagnosis, Treatment, and Follow-up.
Schilsky ML. Schilsky ML. Clin Liver Dis. 2017 Nov;21(4):755-767. doi: 10.1016/j.cld.2017.06.011. Epub 2017 Aug 10. Clin Liver Dis. 2017. PMID: 28987261 Review.
Consideration of a diagnosis of Wilson disease is still the critical factor in testing for and establishing disease diagnosis. In association with other clinical and biochemical tests, liver biopsy results and molecular genetic testing can also be used to gen …
Consideration of a diagnosis of Wilson disease is still the critical factor in testing for and establishing disease dia …
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.
Schilsky ML, Czlonkowska A, Zuin M, Cassiman D, Twardowschy C, Poujois A, Gondim FAA, Denk G, Cury RG, Ott P, Moore J, Ala A, D'Inca R, Couchonnal-Bedoya E, D'Hollander K, Dubois N, Kamlin COF, Weiss KH; CHELATE trial investigators. Schilsky ML, et al. Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1092-1102. doi: 10.1016/S2468-1253(22)00270-9. Epub 2022 Sep 30. Lancet Gastroenterol Hepatol. 2022. PMID: 36183738 Clinical Trial.
BACKGROUND: Wilson disease is an inherited disorder of copper transport. Whereas penicillamine is used therapeutically to re-establish copper balance, trientine is indicated for patients with penicillamine intolerance. We aimed to compare penicillamine with …
BACKGROUND: Wilson disease is an inherited disorder of copper transport. Whereas penicillamine is used therapeutically to re-e …
EASL-ERN Clinical Practice Guidelines on Wilson's disease.
European Association for the Study of the Liver. European Association for the Study of the Liver. J Hepatol. 2025 Feb 22:S0168-8278(24)02706-5. doi: 10.1016/j.jhep.2024.11.007. Online ahead of print. J Hepatol. 2025. PMID: 40089450
Wilson's disease is an autosomal recessive disorder of copper metabolism which affects the liver, brain and other organs. ...Pharmacological therapy comprises chelating agents (penicillamine, trientine) and zinc salts, while only chelators are recommended for …
Wilson's disease is an autosomal recessive disorder of copper metabolism which affects the liver, brain and other organs. ...P …
Wilson Disease.
Immergluck J, Grant LM, Anilkumar AC. Immergluck J, et al. 2025 Apr 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. 2025 Apr 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 28723019 Free Books & Documents.
Wilson disease, also known as hepatolenticular degeneration, is a rare autosomal recessive disorder caused by mutations in the ATP7B gene, leading to abnormal copper accumulation in the liver, brain, cornea, and other organs. ...If untreated, Wilson …
Wilson disease, also known as hepatolenticular degeneration, is a rare autosomal recessive disorder caused by mu …
Wilson Disease Agents.
[No authors listed] [No authors listed] 2020 Jul 25. LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2020 Jul 25. LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644190 Free Books & Documents. Review.
Wilson disease is an inherited abnormality of copper metabolism that leads to excess copper accumulation and injury to liver, brain and other organs. ...Copper chelating agents available in the United States include penicillamine, trientine and dimercaprol. T …
Wilson disease is an inherited abnormality of copper metabolism that leads to excess copper accumulation and injury to liver, …
Wilson Disease.
Weiss KH, Schilsky M. Weiss KH, et al. 1999 Oct 22 [updated 2023 Jan 12]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026. 1999 Oct 22 [updated 2023 Jan 12]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026. PMID: 20301685 Free Books & Documents. Review.
MANAGEMENT: Treatment of manifestations: Lifelong medical interventions to prevent/treat copper accumulation need to be instituted as soon as possible in all individuals with Wilson disease whether they are asymptomatic (i.e., individuals with biallelic ATP7B pathog …
MANAGEMENT: Treatment of manifestations: Lifelong medical interventions to prevent/treat copper accumulation need to be instituted as soon a …
Wilson disease-treatment perspectives.
Litwin T, Dzieżyc K, Członkowska A. Litwin T, et al. Ann Transl Med. 2019 Apr;7(Suppl 2):S68. doi: 10.21037/atm.2018.12.09. Ann Transl Med. 2019. PMID: 31179305 Free PMC article. Review.
Wilson disease (WD) is a genetic disorder caused by pathological tissue copper accumulation with secondary damage of affected organs (mainly, but not limited to, the liver and brain). ...Currently, research is mainly focused on: (I) new agents with better safety pro …
Wilson disease (WD) is a genetic disorder caused by pathological tissue copper accumulation with secondary damage of affected …
364 results